Yet, the clinical utility of established biomarkers is limited in particular by their lack of sensitivity for the early detection of HF. Metabolomics of plasma samples was performed by both untargeted and targeted GC-MS and LC-MS/MS. In the initial single center identification phase metabolites were nominated for multimarker panels and their performance was verified in an independent validation cohort from three clinical centers (in total >800 HF patients and >330 healthy controls). The metabolite multimarkers not only showed a similar diagnostic performance compared to NT-proBNP, but also demonstrated a significant added diagnostic value when combining with NT-proBNP for several HF subgroups. We conclude that metabolomic biomarkers may be useful in the early detection of HF.
New Metabolomics Biomarker for Heart Failure
Video Apr 27, 2015
Behind the Science, S2 Ep8: Dimple Shah on how to tell if rice is organicVideo
Jen talks with Dimple Shah about how analytical science is used and the sensitivity of LC-MS/MS required to detect pesticide residues in rice, and unexpected detection of residues in an organic rice sample.WATCH NOW
Scientist Feedback on the NanoDrop One Microvolume UV-Vis SpectrophotometerVideo
Watch this testimonial video with a University of Cambridge scientist who studies the chemical biology of nucleic acids.WATCH NOW